SNN

+ Watchlist + Portfolio

Smith & Nephew SNATS, Inc.

Regulated industry Physical products Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $26.42
52-Week Range: $26.12 – $37.51
Market Cap: $11.28B
P/E (TTM): 18.33
EPS (TTM): 1.47
Dividend Yield: 3.01%

Advanced Metrics

Price/Book: 11.07
PEG Ratio: 1.01
Return on Equity: 11.85%
Return on Assets: 5.16%
Gross Margin: 68.44%
Operating Margin: 14.47%
Profit Margin: 10.08%
Current Ratio: 2.14
Debt/Equity: 0.73
Total Debt: $3.78B
Free Cash Flow: $1.06B
Revenue Growth: 4.60%
Earnings Growth: 5.70%
Enterprise Value: $59.25B

SNN Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$5.21B	$5.55B	$5.81B	$6.16B
Cost of Revenue	$1.54B	$1.73B	$1.76B	$1.97B
Gross Profit	$3.67B	$3.82B	$4.05B	$4.19B
Research & Development	$345.00M	$339.00M	$289.00M	$296.00M
Selling, General & Admin	$2.44B	$2.60B	$2.65B	$2.79B
Operating Expenses	$3.04B	$3.20B	$3.19B	$3.33B
Operating Income	$634.00M	$620.00M	$860.00M	$857.00M
EBITDA	$874.00M	$956.00M	$1.22B	$1.53B
Pretax Income	$235.00M	$290.00M	$498.00M	$779.00M
Income Tax	$12.00M	$27.00M	$86.00M	$154.00M
Net Income	$223.00M	$263.00M	$412.00M	$625.00M
Diluted EPS	0.50	0.60	0.94	1.43
Diluted Shares	446.00M	436.88M	438.30M	436.45M

SNN Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$350.00M	$302.00M	$619.00M	$557.00M
Inventory	$2.21B	$2.40B	$2.39B	$2.12B
Current Assets	$3.86B	$4.03B	$4.42B	$4.10B
Total Assets	$9.97B	$9.99B	$10.35B	$10.46B
Current Liabilities	$1.72B	$2.27B	$1.53B	$1.59B
Long-Term Debt	$2.56B	$2.17B	$3.12B	$3.03B
Total Debt	$2.87B	$3.08B	$3.32B	$3.33B
Total Liabilities	$4.71B	$4.77B	$5.09B	$5.17B
Retained Earnings	$5.03B	$4.91B	$5.02B	$5.32B
Shareholders' Equity	$5.26B	$5.22B	$5.26B	$5.29B
Working Capital	$2.14B	$1.76B	$2.89B	$2.51B
Net Debt	$2.33B	$2.58B	$2.51B	$2.55B

SNN Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$468.00M	$608.00M	$987.00M	$1.28B
Capital Expenditure	-$358.00M	-$427.00M	-$381.00M	-$433.00M
Free Cash Flow	$110.00M	$181.00M	$606.00M	$852.00M
Depreciation & Amortisation	$548.00M	$527.00M	$555.00M	$574.00M
Stock-Based Compensation	$40.00M	$39.00M	$40.00M	$43.00M
Investing Cash Flow	-$472.00M	-$448.00M	-$569.00M	-$406.00M
Financing Cash Flow	-$926.00M	-$200.00M	-$86.00M	-$955.00M
Dividends Paid	-$327.00M	-$327.00M	-$327.00M	-$330.00M
Share Repurchases	-$158.00M	$0.00	$0.00	-$502.00M
Net Change in Cash	-$930.00M	-$40.00M	$332.00M	-$76.00M

SNN Balance Sheet statement, quarterly periods, in USD
USD	Q4 2024	Q2 2025	Q4 2025
Cash & Equivalents	$619.00M	$676.00M	$557.00M
Inventory	$2.39B	$2.47B	$2.12B
Current Assets	$4.42B	$4.63B	$4.10B
Total Assets	$10.35B	$10.69B	$10.46B
Current Liabilities	$1.53B	$1.54B	$1.59B
Long-Term Debt	$3.12B	$3.15B	$3.03B
Total Debt	$3.32B	$3.45B	$3.33B
Total Liabilities	$5.09B	$5.16B	$5.17B
Retained Earnings	$5.02B	$5.12B	$5.32B
Shareholders' Equity	$5.26B	$5.54B	$5.29B
Working Capital	$2.89B	$3.09B	$2.51B
Net Debt	$2.51B	$2.57B	$2.55B

Market Snapshot

About

Smith & Nephew is a global medical technology company specializing in orthopedics, sports medicine, and advanced wound management. The company designs and manufactures technology that helps healthcare professionals improve patient outcomes. Smith & Nephew operates in more than 100 countries and has been pioneering medical solutions since 1856.